990 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: JNJ-56021927
3 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
4 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
5 Recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention:
6 Recruiting CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Other: CEUS and targeted biopsies;   Other: MRI and targeted biopsies
7 Recruiting Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: Autologus elutriated monocyte placebo vaccine;   Biological: ME TARP vaccine
8 Recruiting Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Metastatic Prostate Cancer
Intervention:
9 Recruiting A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Condition: Prostatic Neoplasms
Intervention: Other: Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
10 Recruiting A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Castration-resistant Prostate Cancer Metastatic to Bone
Interventions: Procedure: Blood Tests;   Procedure: CT scan and bone scan;   Procedure: FACBC PET/MRI in a subset of participants
11 Recruiting Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Docetaxel;   Dietary Supplement: Lycopene
12 Recruiting Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: dietary intervention (tangerine tomato juice);   Dietary Supplement: dietary intervention (red tomato juice);   Other: questionnaire administration;   Other: Correlative studies
13 Recruiting A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:
14 Recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
15 Recruiting A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Conditions: Adenocarcinoma of the Prostate;   Bone Metastases;   Soft Tissue Metastases;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Drug: Ranolazine
16 Recruiting Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Biological: JNJ-64041809 (Cohort 1A and 1B);   Biological: JNJ-64041809 (Cohort 2A and 2B)
17 Recruiting A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: JNJ 56021927;   Drug: Drug Cocktail;   Drug: Pioglitazone;   Drug: Rosuvastatin
18 Recruiting An Efficacy and Safety Study of JNJ-56021927 (ARN-509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ-56021927;   Drug: Bicalutamide;   Drug: Bicalutamide Placebo;   Drug: JNJ-56021927 Placebo;   Drug: GnRH (agonist);   Radiation: 74-80 Grays (units of radiation)
19 Not yet recruiting Focal Therapy for Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Radiation: Brachytherapy
20 Recruiting 18F-DCFBC PET/CT in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: 18F DCFBC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years